Paul Finger Inventions Information

Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York specializing in ocular oncology (ocular tumors, orbital disease and ophthalmic radiation therapy). Dr. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the Director of The New York Eye Cancer Center and Ocular Tumor Services at New York University and The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital. He also served two terms as Chairman of the American Joint Committee on Cancer Ophthalmic Oncology Task Force developing the first consensus staging system for ocular cancers, he developed and served as Chair of The American Brachytherapy Society’s 2014 Committee that provided consensus guidelines for ophthalmic plaque brachytherapy for choroidal melanoma and retinoblastoma, he was the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. Dr. Finger earned his MD from Tulane University School of Medicine, served his internship at St. Vincent’s Medical Center in New York City, and completed a residency at The Manhattan Eye, Ear and Throat Hospital in New York City, New York. He finished a fellowship in Ocular tumor, Orbital disease and Ophthalmic Radiation Therapy with Samuel Packer, MD at North Shore University Hospital-Cornell University Medical College. Dr. Finger is a life member of the American Academy of Ophthalmology, the American Joint Committee on Cancer, the Commission on Cancer, the Retina Society, the American Society of Retinal Specialists, The International Council of Ophthalmology, the Union for International Cancer Control, the International Society of Ophthalmic Oncology and the American Society for Radiation Oncology.

Consultant or Advisory Board: Dr. Finger is the President and Chief Executive officer of LV Liberty Vision Corporation (http://libertyvision.com).

Dr. Finger received his medical doctorate from Tulane Medical School in 1982. He completed his residency at Manhattan Eye, Ear and Throat Hospital, and his fellowship in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy with Samuel Packer MD at North Shore Hospital - Cornell University Medical College in Manhasset, New York.

He is now a Clinical Professor of Ophthalmology at New York University School of Medicine. Dr. Finger is the founding director of the Ocular Tumor Service at the New York Eye and Ear Infirmary of Mount Sinai and serves Tisch, Bellevue and Manhattan Eye, Ear and Throat Hospitals. Dr. Finger has established The New York Eye Cancer Center on the upper east side of New York City, USA where he sees private patients.

Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology. He was asked to Chair, the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer for the 7th and 8th editions. Dr. Finger was asked to write the chapters on eye cancer staging for the UICC. He was also asked to write the Intraocular Melanoma Chapter for the widely used medical textbook, Cancer, Edited by DeVita, Hellman and Rosenberg.

His research has focused on melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma,squamous carcinoma, metastatic cancer to the eye and orbital tumors.

He has helped produce multiple medical textbooks and chapters on eye cancer.

Under the slogan, "Think of sunglasses as sunblock for your eyes," Dr. Finger has campaigned on television to increase the use of sunglasses in order to prevent eye cancers before they happen.

Complete article available at this page.